IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Subscribe To Our Newsletter & Stay Updated